Replies to post #67392 on Biotech Values

[DewDiligence]

Two Xience factoids:

1. Xience/Promus has a >50% DES share in the US only three months after launch.

2. Xience/Promus has the leading market share in every country in which it has been launched.

(Source: today’s ABT CC)